Back to Search Start Over

Early predictors of intensive care unit admission among COVID-19 patients in Qatar.

Authors :
Abuyousef S
Alnaimi S
Omar NE
Elajez R
Elmekaty E
Abdelfattah-Arafa E
Barazi R
Ghasoub R
Rahhal A
Hamou F
Al-Amri M
Karawia A
Ajaj F
Alkhawaja R
Kardousha A
Awaisu A
Abou-Ali A
Khatib M
Aboukamar M
Al-Hail M
Source :
Frontiers in public health [Front Public Health] 2024 Mar 20; Vol. 12, pp. 1278046. Date of Electronic Publication: 2024 Mar 20 (Print Publication: 2024).
Publication Year :
2024

Abstract

Background: COVID-19 is associated with significant morbidity and mortality. This study aimed to explore the early predictors of intensive care unit (ICU) admission among patients with COVID-19.<br />Methods: This was a case-control study of adult patients with confirmed COVID-19. Cases were defined as patients admitted to ICU during the period February 29-May 29, 2020. For each case enrolled, one control was matched by age and gender.<br />Results: A total of 1,560 patients with confirmed COVID-19 were included. Each group included 780 patients with a predominant male gender (89.7%) and a median age of 49 years (interquartile range = 18). Predictors independently associated with ICU admission were cardiovascular disease (adjusted odds ratio (aOR) = 1.64, 95% confidence interval (CI): 1.16-2.32, p = 0.005), diabetes (aOR = 1.52, 95% CI: 1.08-2.13, p = 0.016), obesity (aOR = 1.46, 95% CI: 1.03-2.08, p = 0.034), lymphopenia (aOR = 2.69, 95% CI: 1.80-4.02, p < 0.001), high AST (aOR = 2.59, 95% CI: 1.53-4.36, p < 0.001), high ferritin (aOR = 1.96, 95% CI: 1.40-2.74, p < 0.001), high CRP (aOR = 4.09, 95% CI: 2.81-5.96, p < 0.001), and dyspnea (aOR = 2.50, 95% CI: 1.77-3.54, p < 0.001).<br />Conclusion: Having cardiovascular disease, diabetes, obesity, lymphopenia, dyspnea, and increased AST, ferritin, and CRP were independent predictors for ICU admission in patients with COVID-19.<br />Competing Interests: AA-A was an employee of Astalles Pharma Global Development, Inc. at the time of the study. AA-A is currently affiliated with Takeda Pharmaceuticals. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2024 Abuyousef, Alnaimi, Omar, Elajez, Elmekaty, Abdelfattah-Arafa, Barazi, Ghasoub, Rahhal, Hamou, Al-Amri, Karawia, Ajaj, Alkhawaja, Kardousha, Awaisu, Abou-Ali, Khatib, Aboukamar and Al-Hail.)

Details

Language :
English
ISSN :
2296-2565
Volume :
12
Database :
MEDLINE
Journal :
Frontiers in public health
Publication Type :
Academic Journal
Accession number :
38572008
Full Text :
https://doi.org/10.3389/fpubh.2024.1278046